TSANZ home

Results for "physio for cystic fibrosis"

Home 5 Search query for: physio for cystic fibrosis
Results for "physio for cystic fibrosis"
VOLUME 7.05 – JUNE 2022

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 7.05 – JUNE 2022

VOLUME 6.05 – JULY 2021

Research Roundup:

May 2021

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

Enjoy the May edition of your Research Roundup.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

$300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

(Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

“This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

“We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

“The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

TSANZ would like to congratulate the following Award winners.

TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

Open Awards

Thoracic Society Awards

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

Asthma Australia Research Grant and Workshop

Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

  • Aboriginal and Torres Strait Islander People
  • People facing socioeconomic disadvantage
  • People from culturally and linguistically diverse backgrounds.

We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

    Workshop  details

    1. Culturally and linguistically diverse backgrounds

    When: Wednesday 26th May 11-12:30
    Where: Ethnic Community Council Victoria

    1. People facing socioeconomic disadvantage
      Tuesday 25th May 2-3:30pm
    1. Aboriginal and Torres Strait Islander People
      TBC – please register interest

    If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

    2021 Australian Museum Eureka Prizes

    Do you know someone making a difference in their field?

    Entries to the 2021 Australian Museum Eureka Prizes are now open!

    This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

    There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

    If you know an individual or team doing outstanding work, why not encourage them to enter?

    Entries close 7pm AEST Friday 28 May

    VIEW THE FULL PRIZE PROGRAM

    Respirology – Editor’s Choice

    Respirology Issue 26.4 April 2021

    Central airway collapse is related to obesity independent of asthma phenotype

    Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

    DOI: 10.1111/resp.14005

    Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

    Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

    DOI: 10.1111/resp.13978

    Surveys and Research

    SURVEY OF LUNG CANCER CARE IN AUSTRALIA

    We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

    • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
    • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
    • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

    Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

    Thank you for your time.

    Prof Fraser Brims
    Curtin Medical School
    fraser.brims@curtin.edu.au 

    GP PARTICIPATION REQUIRED

    Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

    Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

    All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

    The survey can be accessed by clicking HERE.

    The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

     

    TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

    A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

    This study has now been completed and below is a summary of the findings from this work.

    The top 3 priorities rank by people with PF and caregivers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. What medications can improve lung function in people with PF?
    3. What are the causes of PF?

    The top 3 priorities rank by people with healthcare professionals/researchers were:

    1. What medications can reverse scarring in the lungs of people with PF?
    2. How can we prevent PF?
    3. What are the causes of PF?

    The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

    (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

    The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

    Yours sincerely,

    Anne Holland
    Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

    TBPod

    The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

    Can you help TSANZ make a difference?

    Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

    1. Making a donation to our Benevolent Fund

    The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
    CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    2. Making a donation to support research

    With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
    Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

    3. Establishing a named award

    For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

    4. Leave TSANZ a gift in your will

    If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
    If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

    5. TSANZ New Zealand Branch Incorporated 

    New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
    CLICK HERE to make a donation.

    Thank you for your continued support of TSANZ.

    VOLUME 7.05 – JUNE 2022

    VOLUME 6.04 – MAY 2021

    Research Roundup:

    May 2021

    Welcome Message

    Welcome to another edition of our TSANZ Research Roundup. It was fantastic to see so many people tune-in to our first ever virtual conference earlier this month. I would like to offer a huge congratulations to everyone who has continued to champion respiratory research by adapting approaches and pushing through despite the COVID-19 pandemic. The presentations on display were testimony to our society of dedicated and steadfast professionals.

    I am honoured to be taking over as Chair of the Research Sub-Committee from Professor Sandy Hodge, who has done a brilliant job of leading our collective interests over the past four years. If there is anything the committee or I can do to help support your research activities, please do not hesitate to get in touch.

    We are please to announce that over $300,000 has been awarded for respiratory research excellence in 2021. Huge congratulations to all the award recipients and good luck with your research. Two awards are currently open, being a TSANZ and National Asthma Council Australia Career Development Fellowship and a NZ Branch travel grant closing 31st of May and 8th of August respectively. There is an Asthma Australia Research Grant and Workshop on offer later this month and calls for applicants in the 2021 Australian Museum Eureka Prizes are open until the 28th of May.

    Check out The Limbic, Respirology Editor’s Choice and Respiratory Research Review segments for a snapshot of some great respiratory research going on. Finally, if you have an interest in lung cancer care, acute exacerbations of COPD or helping to inform the top 10 research priorities for pulmonary fibrosis, click on the survey links below.

    Enjoy the May edition of your Research Roundup.

    A/Prof Kristin Carson-Chahhoud
    Chair, Research Sub-Committee 

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    $300,000 FOR LUNG DISEASE RESEARCH ANNOUNCED

    (Saturday, 1st May 2021): Over $300,000 in lung research investment was announced this weekend at the Respiratory Research Excellence Awards, presented in a virtual format alongside the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science (TSANZSRS 2021).

    This prestigious selection of awards are presented to TSANZ members who are at various stages of their career and doing outstanding work. These awards aim to support individuals through project funding, fellowships and travel grants.

    “This funding enables our researchers to learn more and develop their skills, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” said TSANZ President Elect Professor John Upham.

    “We’re honoured to be able to support some of Australia’s most innovative researchers working on lung disease and lung health. This research will make a difference to the lives of the 1 in 4 Australians with lung disease,” he said.

    Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of TSANZSRS – are pleased to announce awards from Cystic Fibrosis Australia, the National Asthma Council Australia, Lung Foundation Australia and the Centre of Research Excellence in Pulmonary Fibrosis.

    “The TSANZ is privileged to support a diverse awards program that recognises the best and brightest minds in respiratory health that will shape the lung health of our communities into the future” said TSANZ CEO, Dr Graham Hall.

    The research awards are supported by the generosity of private donations, sponsorship and leveraged financing from recipients’ institutions. Thank you to our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge and build capacity in the respiratory workforce, with the overall goal to prevent, cure and relieve disability from lung disease.

    2021 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

    TSANZ would like to congratulate the following Award winners.

    TSANZ Janet Elder Travel Award – Early  Career – Maggie Lam, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Melissa Preissner, Monash University

    TSANZ Janet Elder Travel Award – Early Career – Mariana Hoffman Barbosa, Monash University

    BI NZ Primary Care Grant – Sarah Mooney, Auckland University of Technology

    Past President’s Scholarship Award – Elena Schneider-Futschik, The University of Melbourne

    TSANZ Peter Phelan Research Award – Thomas Iosifidis, Curtin University and Telethon Kids Institute

    TSANZ/Maurice Blackburn GIA – Keshav Raj Paudel, University of Technology Sydney

    TSANZ Robert Pierce GIA for ILH – Peter Wark, University of Newcastle and Hunter Medical Research Institute

    Ann Woolcock New Investigator Award – Nicole Sheers, Austin Health, University of Melbourne

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Gang Liu, Ashleigh Philp & Laura Glenn, UTS, UNSW & The University of Sydney

    CREATE Grant-in-Aid For new collaborative research between CREATE Fellows (CRE-PF and Lung Foundation Australia) – Laura Glenn, Alan Teoh, Hayley Barnes & John Mackintosh, RPAH, Alfred Health & Prince Charles Hospital

    PACT Grant-in-Aid For Investigator Led Pulmonary Fibrosis Clinical Research (Lung Foundation Australia and CRE-PF) – Yet Hong Khor & Christopher Ryerson, Austin Health & University of British Columbia

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Joanna Lee, Monash University

    CREATE Hope PhD Scholarships in Pulmonary Fibrosis (Lung Foundation Australia and CRE-PF) -Claudia Sim, Monash University

    Open Awards

    Thoracic Society Awards

    TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

    TSANZ NZ Branch ASM 2021 Travel Grant – closing 8 August 2021

    Asthma Australia Research Grant and Workshop

    Asthma Australia would like to invite you to a workshop which aims to share ideas and invoke research partnerships around issues relevant to people disproportionately affected by asthma. At the end of the meeting, Asthma Australia will re-announce a $300,000 Strategic Alliance grant for such work.

    At Asthma Australia, we are committed to doing things differently in our quest to help people live freely from their disease and hope you are ready to join us. Thanks to the Ray O’Donnell Belgrave Lions Asthma Research Fund, we are seeking to fund research from Victorian-led research collaborations to answer the evidence gaps and develop solutions for people from the three following population segments disproportionately affected by asthma:

    • Aboriginal and Torres Strait Islander People
    • People facing socioeconomic disadvantage
    • People from culturally and linguistically diverse backgrounds.

    We will be holding one workshop (up to 90 minutes) for each population segment and want you to attend.

    At the workshops you will hear why this research funding is a priority in Australia for people with asthma. We will facilitate a discussion among participants about why these inequities persist and share ideas around potential collaborations and novel approaches that aim to address them. After the workshops, applications will open to apply for the $300,000 Strategic Alliance Grant. 

      Workshop  details

      1. Culturally and linguistically diverse backgrounds

      When: Wednesday 26th May 11-12:30
      Where: Ethnic Community Council Victoria

      1. People facing socioeconomic disadvantage
        Tuesday 25th May 2-3:30pm
      1. Aboriginal and Torres Strait Islander People
        TBC – please register interest

      If you are interested in applying for this grant, please contact Asthma Australia (via research@asthma.org.auwith your name, organisation and the workshop you would like to attend.  

      2021 Australian Museum Eureka Prizes

      Do you know someone making a difference in their field?

      Entries to the 2021 Australian Museum Eureka Prizes are now open!

      This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

      There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

      If you know an individual or team doing outstanding work, why not encourage them to enter?

      Entries close 7pm AEST Friday 28 May

      VIEW THE FULL PRIZE PROGRAM

      Respirology – Editor’s Choice

      Respirology Issue 26.4 April 2021

      Central airway collapse is related to obesity independent of asthma phenotype

      Swati A. Bhatawadekar, Ubong Peters, Ryan R. Walsh, Nirav Daphtary, Erick S. Maclean, Vitor Mori, Kevin Hodgdon, C. Matthew Kinsey, David A. Kaminsky, Jason H.T. Bates and Anne E. Dixon

      DOI: 10.1111/resp.14005

      Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial

      Tomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, Yusuke Kaida, Taisuke Akamatsu, Hideki Kusagaya, Yasuomi Satake, Kazutaka Mori, Masashi Mikamo, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, and Takafumi Suda

      DOI: 10.1111/resp.13978

      Surveys and Research

      SURVEY OF LUNG CANCER CARE IN AUSTRALIA

      We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

      • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
      • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
      • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

      Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

      Thank you for your time.

      Prof Fraser Brims
      Curtin Medical School
      fraser.brims@curtin.edu.au 

      GP PARTICIPATION REQUIRED

      Investigators from Monash University are conducting a RACGP-funded national survey of GPs regarding the management of patients with acute exacerbations of COPD.

      Acute exacerbations of COPD are a leading cause of hospitalisation, with a substantial proportion of cases being potentially preventable. We are seeking GPs to complete a short survey that aims to better understand current practice and unmet needs in order to optimise care for these patients. Due to the current COVID-19 vaccination rollout across Australia, it is very challenging to secure participation. Any assistance to distribute this among your contacts is greatly appreciated.

      All eligible participants who complete the survey will have the chance to win one of two $250 gift vouchers, and anyone who completes an optional follow-up qualitative interview will receive a $250 gift voucher.

      The survey can be accessed by clicking HERE.

      The survey has been approved by the Monash University Human Research Ethics Committee (MUHREC ref. 26571). If you have any queries, please contact Dr Bianca Perera at bianca.perera@monash.edu, Dr. Chris Barton at chris.barton@monash.edu or Dr Christian Osadnik (Principal investigator) at christian.osadnik@monash.edu.

       

      TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

      A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

      This study has now been completed and below is a summary of the findings from this work.

      The top 3 priorities rank by people with PF and caregivers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. What medications can improve lung function in people with PF?
      3. What are the causes of PF?

      The top 3 priorities rank by people with healthcare professionals/researchers were:

      1. What medications can reverse scarring in the lungs of people with PF?
      2. How can we prevent PF?
      3. What are the causes of PF?

      The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

      (click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

      The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

      Yours sincerely,

      Anne Holland
      Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

      TBPod

      The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      VOLUME 7.05 – JUNE 2022

      VOLUME 5.05 – AUGUST 2020

      Research Roundup:

      August 2020

      .

      Welcome Message

      Welcome to the August Research Roundup. We hope you are all staying well in these uneasy COVID-19 times.

      This month we are pleased to open two new awards. Firstly, we are very excited to announce and gratefully acknowledge the generous donation from our immediate past president, Prof Allan Glanville, to establish the Past Presidents Scholarship Award. We hope that others will join him in supporting this award that will provide both funding for our ECRs and, provide access to professional mentors and networks. Given global travel restrictions, ECRs are encouraged to think creatively when applying and consider the merit in visiting institutions closer to home.

      Secondly, we would like to thank Boehringer Ingelheim New Zealand for supporting a new award for our New Zealand members. The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic. Primary care can include general practice, allied health services, community health and community pharmacy.

      As you would be aware, TSANZ is part of the National COVID-19 Clinical Evidence Taskforce; a living guideline which is continuously updated as new peer reviewed research becomes available. Many of our members are contributing to the COVID-19 research effort. One large multi-centre trial is the ASCOT trial (AustralaSian COVID-19 Trial) which many of our members are involved in. This trial will which be featured in a TSANZ webinar on 17 September 20.

      We are pleased to again be hosting the LFA Awards. These will be opening on the 1st of September, including the Lizotte Family Research Award for IPF Research; Ludwig Engel Grant-in-Aid for Physiological Research; Ivan Cash Grant-in-Aid for IPF Research; and the Cochrane Airways Australia Scholarship. Please see below for more details.

      As TSANZ members we also have the privilege of participating in an increasing number of surveys as detailed below. These include surveys of the Breathe Study: Investigating the role of masks for patients with asthma and COPD against bushfire smoke, Cystic Fibrosis Australia Research and Advocacy Priority Setting, and studies aimed at improving the quality of clinical trials evaluating  the management of COPD exacerbations, nurses’ attitudes to caring for people with intellectual disability, global current practices of mechanical ventilation management in COVID-19 patients, self-management for pulmonary fibrosis and  identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of PF. These are all very worthy studies and we encourage your participation.

      Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the August edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      TSANZ Past President’s Award

      The TSANZ Past Presidents Scholarship Award aims to support early career researchers (ECRs) who do not have the resources available to them via their institution or workplace to:

      1)  Develop their presentation of research skills, and/or

      2) Present their research at a national or international professional conference of their choice.

      The Scholarship will cover

      • Airfares
      • Accommodation
      • Ground travel and transfers
      • Registration
      • Per Diem Daily Allowance in accordance with the ATO Reasonable Travel and Meal Allowance Guide

      Up to a maximum of AUD 7000, with the amount to be paid dependent on the delivery of receipts for the expenses incurred above.

      Additionally, the Scholarship will provide the awardee with support from a TSANZ Past President to review their presentation and provide feedback and professional development on research presentation skills. The Past President will be determined by TSANZ.

      Please visit the TSANZ Awards Submissions Portal for more information.

      Boeringer Ingelheim New Zealand Primary Care Grant

      The Boehringer Ingelheim New Zealand Primary Care Grant aims to support research which will address the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

      Primary care can include general practice, allied health services, community health and community pharmacy.

      The grant is valued at NZD 5000 and will support studies for one year only.

      Please visit the TSANZ Awards Submissions Portal for more information.

      CREATE Grant-in-Aid Funding Opportunity

      In 2020, there is a CREATE Grant-in-Aid opportunity for the award of one or more grants valued at a total of $7,000 to assist new collaborative investigator led Pulmonary Fibrosis research within the group of CREATE Fellows. The objective of the CREATE Grant-in-Aid is to encourage new research which meets the aims of the CRE-PF and builds collaborations between CREATE Fellows drawn together through the CRE-PF.

      Please visit the LFA Awards Submissions Portal for more information.

      LFA Awards

      Lung Foundation Australia and its partners are excited to announce the following Research Grants will be open to application from 1 September 2020. For more information visit: https://lungfoundation.com.au/research/awards-and-grants/apply-for-funding/

      YEAR OPEN

      YEAR UNDERTAKEN

      Award 

      Target area 

      Value

      Duration

      Timeline

      2020

      2021

      Lung Foundation Australia – Lizotte Family Grant for IPF Research 

      IPF 

       $        5,000.00 

      1 year

      1 September 2020 (close 13 October, announced 11 Dec) 

      2020

      2021

      Lung Foundation Australia – Ludwig Engel Grant-in-Aid for Physiological Respiratory Research

      IPF 

       $        5,000.00 

      1 year

      1 September 2020 (close 13 October, announced 11 Dec) 

      2020

      2021

      Lung Foundation Australia -Ivan Cash Grant-in-Aid For IPF Research

      IPF 

       $        5,000.00 

      1 year

      1 September 2020 (close 13 October, announced 11 Dec) 

      2020

      2021

      Lung Foundation Australia -Cochrane Airways Australia 
      Scholarship

      Systematic Review

      $        2,500.00 

      1 year

      1 September 2020 (close 13 October, announced 11 Dec) 

       

      LFA 2020 Research Grant recipients

       

      Congratulations to the recipients of the Lung Foundation Australia 2020 Research Grants.

      2019

      2020

      Lung Foundation Australia – Ellen Yates Memorial Grant in Aid for Lung Cancer Research

      $20,000.00 

      Edith Cowan University

      Dr. Afaf Abed

      2019

      2020

      Lung Foundation Australia – Deep Manchanda Fellowship in Lung Cancer Research

      $   160,000.00 

      The Garvan Institute of Medical Research

      Dr. Venessa Chin

      2019

      2020

      Lung Foundation Australia – Di Cox PhD Scholarship in IPF Research 

       $      45,000.00 

       University of Sydney

      Dr. Laura Glenn

      2019

      2020

      Lung Foundation Australia – Brian Eaton PhD Scholarship in IPF Research 

       $      45,000.00 

       University of Sydney

      Dr. Matthew Parker

      2019

      2020

      Lung Foundation Australia – Lizotte Family Grant for IPF Research

      $        5,000.00 

      Austin Health

      Dr Yet Hong Khor

      2019

      2020

      Lung Foundation Australia – Ludwig Engel Grant-in-Aid for Physiological Respiratory Research

      $        5,000.00 

      The Children’s Hospital at Westmead

      Dr. Alexander Wong 

      2019

      2020

      Lung Foundation Australia – Ivan Cash Grant-in-Aid For IPF Research

      $        5,000.00 

      RMIT University 

      Dr. Paris Papagianis

      2019

      2020

      Lung Foundation Australia – Cochrane Airways Australia 
      Scholarship

      $        2,500.00 

      University of South Australia

      Kelsey Sharrad

       

      Australasian Severe Asthma Registry (ASAR) Annual Report 2019

       

      TSANZ is excited to share the ASAR 2019 Annual Report with you!

      In 2019, TSANZ in collaboration with the Australasian Severe Asthma Network (ASAN), successfully transitioned the Severe Asthma Web-based Database (SAWD) to ASAR – a Clinical Quality Registry (CQR). ASAR is now uniquely positioned to collect longitudinal data (10-year follow-up) on a well-characterised severe asthma cohort in Australia and New Zealand with the capability to add modules of specific interest, for example, the Australasian Benralizumab Registry.

      To view the ASAR 2019 Annual Report please click here.

      Respirology – Editor’s Choice 

      Respirology Issue 25.7 July 2020

       

      Sputum transcriptomics implicates increased p38 signalling activity in severe asthma

      Katherine J. Baines, Michael Fricker, Vanessa M. McDonald, Jodie L. Simpson, Lisa G. Wood, Peter A.B. Warik, Heather E. Macdonald, Andrew Reid and Peter G. Gibson

       

      The authorship team from Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia

      DOI: 10.1111/resp.13749

       

      Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study

      Hye Yun Park, Danbee Kang, Hyun Lee, Sun Hye Shin, Minwoong Kang, Sunga Kong, Chin Kook Rhee, Juhee Cho and Kwang Ha Yoo

       

      The Korean COPD And Outcomes Study Team. From left to right: (Top) Kwang Ha Yoo, Danbee Kang, Sun Hye Shin, (Bottom) Juhee Cho and Hye Yun Park

      DOI: 10.1111/resp.13678

      Respirology Issue 25.8 August 2020

       

      Ventilation heterogeneity and oscillometry predict asthma control improvement following step-up inhaled therapy in uncontrolled asthma

      Francesca S.M. Tang, Sandra Rutting, Catherine E. Farrow, Katrina O. Tonga, Joanna Watts, Jessica R. Dame-Carrol, Amy Bertolin, Gregory G. King, Cindy Thamrin and David G. Chapman

       

      The Airway Physiology and Imaging Group from the Woolcock Institute of Medical Research in Sydney, Australia, as part of the overall research team. From left to right: Prof. Gregory King, Dr David Chapman, Dr Sandra Rutting, Dr Katrina Tonga and A/Prof. Cindy Thamrin.

      DOI: 10.1111/resp.13772

       

      Identification and definition of asthma–COPD overlap: The CanCOLD study

      Miriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, Wan C. Tan, Pei Z. Li, Shawn D. Aaron, Andrea Benedetti, Kenneth R. Chapman, Brandie Walker, J. Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy D. Marciniuk, Denis E. O’Donnell, Don D. Sin, Jean Bourbeau for The Cancold Collaborative Research Group and The Canadian Respiratory Research Network

       

      The authorship team on behalf of the CanCOLD Collaborative Research Group and

      the Canadian Respiratory Research Network. From top left to right bottom: Miriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, Wan Tan, Pei Li, Shawn Aaron, Andrea Benedetti, Kenneth Chapman, B Walker, Mark Fitzgerald, Paul Hernandez, François Maltais, Darcy Marciniuk, Denis O’Donnell, Don Sin, Jean Bourbeau

      DOI: 10.1111/resp.13780

      Invitations and surveys

      BREATHE Study

      Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

      Do you live in an area affected by bushfires or bushfire smoke?

      If yes to both, you may be eligible for the BREATHE study.

      We are studying facemasks for prevention of smoke exposure

      Find out more: https://kirby.unsw.edu.au/breathe

      Please register your interest: https://www.surveymonkey.com/r/C96DXJN

      Contact us: e.kpozehouen@unsw.edu.au

      Ethics Approval: HC200477

      CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

      Dear Members of the Thoracic Society of Australia and New Zealand,

      Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

      https://www.surveymonkey.com/r/F38Q8K2

      We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

      To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

       

      INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

      Dear colleagues,

      Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

      To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

      We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

      In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

      • 1-3: Outcomes of limited importance.
      • 4-6: Outcomes that are important but not critical.
      • 7-9: Critical outcomes.

      We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

      In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

      Your opinion in both surveys is extremely important in developing the core outcome set.

      It is crucial that you complete both surveys and we would be very grateful if you can do this.

      Please, take the survey in one of the following languages:

      English: https://delphimanager.liv.ac.uk/COPD/
      Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
      German: https://delphimanager.liv.ac.uk/COPD-GE/
      Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
      Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
      Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
      Russian: https://delphimanager.liv.ac.uk/COPD-RU/
      Greek: https://delphimanager.liv.ac.uk/COPD-GR/
      Danish: https://delphimanager.liv.ac.uk/COPD-DK/
      Italian: https://delphimanager.liv.ac.uk/COPD-IT/

      We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

      Thank you very much in advance,
      Kind regards,
      Associate Prof. Jens-Ulrik Jensen,
      Dr. Alexander Mathioudakis,
      Prof. Jørgen Vestbo,
      On behalf of the study team.

       

      NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

      Dear Colleagues,

      We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

      People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

      By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

      Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

      Caring for People with Intellectual Disability survey

      Thank you for considering our invitation
      A/Prof Nathan Wilson, Western Sydney University
      Dr Peter Lewis, Western Sydney University
      Ms Virginia Howie, Central Queensland University
      Dr Melissa Desroches, University of Massachusetts, Dartmouth

      Kind regards,
      Virginia

       

      GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

      Dear Colleague, 

      You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

      We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

      Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

      If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

      THANK YOU!
      Jaber Alqahtani
      On behalf of the whole international team

       

      INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

      Dear Members of the Thoracic Society of Australia and New Zealand, 

      Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

      Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

      Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

      The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

      If you are interested in participating or would like further information on this study, please contact: 

      Professor Anne Holland (Chief Investigator) 
      Professor of Physiotherapy, 
      Monash University and Alfred Health 
      Email: Anne.Holland@monash.edu 
      Telephone: (03) 9903 0214 

      Ms Joanna Lee (PhD candidate)
      Monash University and Alfred Health
      Email: joanna.lee2@monash.edu
      Mobile: 0431 689 361

      Thank you for your time and consideration of our study. 

       

      IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

      What are the barriers and facilitators to implementing best practice?

      Dear Members of the Thoracic Society of Australia and New Zealand,

      The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

      Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

      Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

      Like more information or interested in participating? Click here

      The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

      If you would like to speak to us about any aspect of this study, please contact:

      Professor Anne Holland
      Professor of Physiotherapy, Monash University and Alfred Health
      Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
      Anne.Holland@monash.edu or (03) 9903 0214

      Thank you for your time and consideration of our study.

      ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

      1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
      1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

       

      Protocol documents and further details are available at www.ascot-trial.edu.au

       

      Can you help TSANZ make a difference?
       

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

      VOLUME 7.05 – JUNE 2022

      VOLUME 5.04 – JUNE 2020

      Research Roundup:

      June 2020

       

      Welcome Message

      Welcome to this exciting update of the Research Roundup.

      Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

      The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

      Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

      Enjoy the June edition of your Research Roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      2020 Respiratory Research Excellence Awards

       

      TSANZ congratulates the following award winners!!!

       

      Ann Woolcock New Investigator Award Winner: Kurtis Budden

      Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

      TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

      TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

      TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

      Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

      Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

      Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

      Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

      TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

      TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

      TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

      TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

      TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

      Janet Elder International Mid-Career Travel Award: David G Chapman

      Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

      Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

      TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

       

      TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

      2020 TSANZ Awards by Nomination

      At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

      TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

      The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

      TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

      This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

      TSANZ Society Medal – Associate Professor Tara Mackenzie

      This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

      Fellowships

      • Professor Richard Beasley
      • Professor Margaret Wilsher
      • Professor Ross Vlahos

      Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

      Congratulations to all!

      Respirology – Editor’s Choice 

      Respirology Issue 25.5 May 2020

       

      Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

      Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

       

      Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

      DOI: 10.1111/resp.13744

       

      Acute exacerbations of fibrotic interstitial lung diseases

      Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

       

      Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

      DOI: 10.1111/resp.13682

      Respirology Issue 25.6 June 2020

       

      Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

      Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

       

      A collection of e-cigarettes and e-liquids for sale to vapers

      DOI: 10.1111/resp.13696

       

      Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

      Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

       

       

      The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

      DOI: 10.1111/resp.13753

      TSANZSRS 2020 Abstracts

      Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

      Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

       

      Invitations and surveys

       

      CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

      Dear Members of the Thoracic Society of Australia and New Zealand,

      Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

      https://www.surveymonkey.com/r/F38Q8K2

      We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

      To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

       

      INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

      Dear colleagues,

      Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

      To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

      We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

      In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

      • 1-3: Outcomes of limited importance.
      • 4-6: Outcomes that are important but not critical.
      • 7-9: Critical outcomes.

      We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

      In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

      Your opinion in both surveys is extremely important in developing the core outcome set.

      It is crucial that you complete both surveys and we would be very grateful if you can do this.

      Please, take the survey in one of the following languages:

      English: https://delphimanager.liv.ac.uk/COPD/
      Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
      German: https://delphimanager.liv.ac.uk/COPD-GE/
      Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
      Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
      Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
      Russian: https://delphimanager.liv.ac.uk/COPD-RU/
      Greek: https://delphimanager.liv.ac.uk/COPD-GR/
      Danish: https://delphimanager.liv.ac.uk/COPD-DK/
      Italian: https://delphimanager.liv.ac.uk/COPD-IT/

      We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

      Thank you very much in advance,
      Kind regards,
      Associate Prof. Jens-Ulrik Jensen,
      Dr. Alexander Mathioudakis,
      Prof. Jørgen Vestbo,
      On behalf of the study team.

       

      NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

      Dear Colleagues,

      We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

      People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

      By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

      Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

      Caring for People with Intellectual Disability survey

      Thank you for considering our invitation
      A/Prof Nathan Wilson, Western Sydney University
      Dr Peter Lewis, Western Sydney University
      Ms Virginia Howie, Central Queensland University
      Dr Melissa Desroches, University of Massachusetts, Dartmouth

      Kind regards,
      Virginia

       

      GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

      Dear Colleague, 

      You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

      We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

      Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

      If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

      THANK YOU!
      Jaber Alqahtani
      On behalf of the whole international team

       

      INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

      Dear Members of the Thoracic Society of Australia and New Zealand, 

      Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

      Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

      Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

      The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

      If you are interested in participating or would like further information on this study, please contact: 

      Professor Anne Holland (Chief Investigator) 
      Professor of Physiotherapy, 
      Monash University and Alfred Health 
      Email: Anne.Holland@monash.edu 
      Telephone: (03) 9903 0214 

      Ms Joanna Lee (PhD candidate)
      Monash University and Alfred Health
      Email: joanna.lee2@monash.edu
      Mobile: 0431 689 361

      Thank you for your time and consideration of our study. 

       

      IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

      What are the barriers and facilitators to implementing best practice?

      Dear Members of the Thoracic Society of Australia and New Zealand,

      The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

      Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

      Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

      Like more information or interested in participating? Click here

      The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

      If you would like to speak to us about any aspect of this study, please contact:

      Professor Anne Holland
      Professor of Physiotherapy, Monash University and Alfred Health
      Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
      Anne.Holland@monash.edu or (03) 9903 0214

      Thank you for your time and consideration of our study.

      ASCOT trial

      ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

      The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

      Potential Treatments for COVID-19

      There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

      ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

      ASCOT Trial Intervention

      Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

      1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
      1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

       

      Protocol documents and further details are available at www.ascot-trial.edu.au

       

      Can you help TSANZ make a difference?
       

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ.

       

      .

       

      VOLUME 7.05 – JUNE 2022

      VOLUME 4.09 NOVEMBER 2019

      Research Roundup:

      November 2019

      .
       

      Welcome Message

      We are now in the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Sub-committee is in full swing reviewing award applications, the SIG convenors are reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2020, we are expecting another large conference, having received approximately 440 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2020.

      Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

      We hope you enjoy this edition of your Research Roundup!

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      Open Awards

       

      Thoracic Society Awards 

      There are three Thoracic Society Awards open:

       

      Lund Foundation Australia Research Awards 

      • Cochrane Airways Australia Scholarship – extended to 15 November 2019

      To download application documents, click here.

       

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      TSANZ Webinar Series

       

      “Tracheostomy tubes and principles of management” with Gavin Fahey

      Event Date: Thursday, 14th of November 2019

      Time: 2:30pm AEDT

      Duration: 45 minutes

      A presentation covering anatomy and physiology, tube selection, principles of nursing and emergency management.

      Only limited places available! Don’t miss out!

      The presenter: Gavin Fahey

      Gavin Fahey currently works as Senior Respiratory Clinical Nurse Consultant (CNC) at Northern Health (NH) leading a team of Respiratory CNCs who since 2018 have collectively contributed to acquisition and management of oxygen services across NH, development of a 4-bed Respiratory Care Unit caring for patients with severe respiratory failure, and improving lung mass services incorporating development of Victoria’s first Specialist Ambulatory Pleural Service. Gavin’s experience includes working within both the Victorian Respiratory Support Service and Tracheostomy and Management Service (Austin Health) utilising his experience and advanced understanding of tracheostomy and ventilation management within the acute and outpatients setting.

      CLICK HERE to register! 

      _______________________________________________________________________________

      Missed out on a webinar? 

      The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

      Respirology – Editor’s Choice

      Respirology Issue 24.11 November 2019

      Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial

      Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton

      DOI: 10.1111/resp.13575

      Nasal High Flow therapy in use

      BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo

      Rebecca L. Harper, Suzanne Maiolo, Rebekah J. Ward, Jemma Seyfang, Michaelia P. Cockshell, Claudine S. Bonder, Paul N. Reynolds

      Putative mechanism of cell therapy upregulating BMPR2 in pulmonary vessels via release of exosomes

      DOI: 10.1111/resp.13552

      Research Project and Survey Requests

       

      Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

      Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

      The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

      EOI applications open: Tuesday, 15 October 2019.
      Closing Date: Monday, 16 December 2019

      Click here for further details

      Workshops and Conferences

      Dear TSANZ Members,

      Lung Foundation Australia, with the support of nursing members of the Australia and New Zealand – Lung Cancer Nurse Forum, invite you to the next workshop in the series: Treatment Modalities and Management of a Stage 3 NSCLC Patient workshop, in Hobart on Friday 29 November 2019.

      These workshops are open to nurses and allied health with an interest in working with and caring for people with lung cancer.

      Date: Friday 29 November 2019

      Time: 9:30am – 12:30pm

      Location: Cancer Support Centre, Royal Hobart Hospital, 48 Liverpool St, Hobart TAS 7000

      Program: Medical experts including nurses, medical oncology and radiation oncology specialists, and allied health professionals will discuss the management of a Stage III unresectable lung cancer patient.

      More information about the agenda and speakers are coming soon. Please see our website for up to date information on this workshop.

      Workshops are free to attend and you will be provided with a certificate for your hours of learning.

      Register here

      Please RSVP by Friday 22 November 2019. Registrations are essential for seating and catering purposes. For more information on the event, please visit our website here.

      For further queries, please contact our information and support centre freecall on 1800 654 301 or email enquiries@lungfoundation.com.au.

      We hope to see you on the day!

      Kind Regards,

      Lung Foundation Australia

       

                                                                                                                                                                    

       

      Can you help TSANZ make a difference?

      Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

      1. Making a donation to our Benevolent Fund

      The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
      CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      2. Making a donation to support research

      With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
      Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

      3. Establishing a named award

      For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

      4. Leave TSANZ a gift in your will

      If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
      If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

      5. TSANZ New Zealand Branch Incorporated 

      New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
      CLICK HERE to make a donation.

      Thank you for your continued support of TSANZ

      VOLUME 7.05 – JUNE 2022

      VOLUME 4.02 APRIL 2019

      Research Roundup:

      April 2019

      .
       

      Welcome Message

      The TSANZSRS19 was a great success and we thank all delegates and exhibitors for supporting respiratory research and professional development once again.

      At TSANZSRS19 respiratory research received a much needed boost of funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and the Gala Dinner. Please find a re-cap of all the Thoracic Society Board Awards and Research Awards below, including the winners of the Special Interest Group Awards.

      During the conference we opened a number of larger TSANZ awards, namely the AstraZeneca Respiratory Research Fellowships, which will support one early-career researcher and one mid-career researcher and the Vertex Cystic Fibrosis Research Awards, which will support one adult CF research project and one paediatric CF research project. There are also opportunities for IPF PhD scholarships and Menarini travel awards from the Lung Foundation. Links to these awards can be found in the Open Awards section below.

      Enjoy the April edition of your research roundup.

      Prof Sandra Hodge

      Chair, Research Sub-Committee

      $1 MILLION FOR LUNG DISEASE RESEARCH ANNOUNCED

      Top lung health bodies raise much needed funds but more investment needed

      (Thursday, 8th April 2019): Over a million dollars in lung research investment was announced over the weekend at the Respiratory Research Excellence Awards at the Australia and New Zealand Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science(TSANZSRS19) on the Gold Coast. The conference brings together Australia and New Zealand’s leading lung health experts to present latest research and improve knowledge and understanding of lung disease.

      The Research Excellence Awards, run for the second year by Thoracic Society of Australia and New Zealand (TSANZ) – the hosts of the conference – alongside the Lung Foundation, Cystic Fibrosis Australia and the National Asthma Council of Australia, provides over 40 researchers with support in the form of project funding, fellowships and travel grants raised through private donations, sponsorship and leveraged financing from recipients’ institutions.

      “We’re honoured to be able to support some of Australia’s greatest minds in lung disease research; research that’s making a difference to the lives of the 1 in 4 Australians with lung disease,” said TSANZ President Elect Professor Bruce Thompson.

      “This funding enables our researchers to build respiratory knowledge and capacity in the respiratory workforce, with the overall goal of preventing, curing and alleviating disability from lung disease. Every dollar invested takes us one step closer to reaching that goal,” he said.

      Despite the success of the Awards, the organisers warn that lung disease research is still grossly underfunded when compared to other diseases. Far more investment is required, they say.

      “It’s important to recognise the exceedingly hard work that our organisations are putting in to raising the profile of respiratory research, and to express our thanks for the contribution of donors, sponsors and institutions This is only our second year and look at what we’ve achieved,” said TSANZ CEO Tanya Buchanan.

      “However, fundraising alone is not the way to manage diseases affecting a quarter of Australians. Lung disease has to attract the same level of research funding enjoyed by other disease areas such as breast, prostate, and heart disease. We look forward to seeing if the implementation of the National Strategic Action Plan for Lung Conditions delivers this,” she said.

      2019 RESPIRATORY RESEARCH EXCELLENCE AWARD WINNERS

      TSANZ would like to congratulate the following Award winners. For information on how to apply for next year’s Awards visit the TSANZ website Research and Awards page.

      Society Medal

      Professor Helen Reddel

      Research Medal

      Professor Philip Hansbro

      Laennec Medal

      Professor Allan R Glanville

      Ann Woolcock New Investigator Award

      Jesse Armitage

      Best training Video

      Elizabeth Salamon, Selena West, Ursula Swan, Sandra Daly

      CSL Behring TSANZ / LFA Alpha-1 Anti-trypsin Deficiency Research Award

      Gang Liu

      Australian Cystic Fibrosis Research Trust Innovation Grant

      Gerard Kaiko, Peter Wark, Shafagh Water, and Adam Jaffe

      TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship

      Kimberly Wang

      Boehringer Ingelheim COPD Research Award 2019

      Tatt Jhong Haw

      Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

      Jane Bourke and Ryan Hoy

      Boston Scientific Research Award for Interventional Pulmonology

      Sanjeevan Muruganandan

      Vertex Cystic Fibrosis Research Awards

      ECFS: Elena Schneider-Futschik

      NACFC: Rebecca Stockwell

      TSANZ Peter Phelan Research Award

      Elena Schneider-Futschik

      TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health

      Gabrielle McCallum

      TSANZ / Boehringer Ingelheim Australia COPD Travel Award

      Alen Faiz

      TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award

      Eskandarain Shafuddin

      TSANZ/JRS Early Career Development Award

      Jemma Seyfang

      Janet Elder International Travel Awards

      Mid-Career Award Recipient: Kimberley Wang

      Early Career Award Recipient 1: Vikas Goyal

      Early Career Award Recipient 2: Yet H Khor

      TSANZ Respiratory Nurse Career Development Award for Indigenous Research

      Betty Poot

      Christine Sullivan

      Maurice Blackburn ASM Travel Award

      Leona Dowman

      Shine a light a lung cancer PhD 2019

      Kanishka Rangamuwa

      David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis Research 2019

      Archana Gaikwad

      Shine a light on lung cancer grant-in-aid

      Surein Arulananda

      Lung Foundation Australia/ Eleanor Greenwood Memorial Grant in Aid for Interstitial Lung Disease Research

      Yet Hong Khor

      Lung Foundation Australia /Lizotte Family Research Award for Interstitial PF Research

      Leona Dowman

      Lung Foundation Australia /Ludwig Engel GIA for Physiological research

      Katrina Tonga

      Lung Foundation Australia /Ivan Cash Research GIA – IPF

      Adelle Jee

      Lung Foundation Australia /Cochrane

      Jenifer Liang

      Shine a light on lung cancer nursing/allied health fellowship in lung cancer research

      Vanessa Brunelli

      Lung Foundation Australia Travel Awards: Menarini Travel Grants

      ERS – Hannah O’Farrell and Jack Bozier

      ATS – Thomas Altree and Razia Zakarya

      APSR – Leanne Ross and Hai Bac Tran

      Lung Foundation Australia/Eleanor Greenwood Memorial ILD Travel Grant

      Cecilia Prele

      Michael Schuliga

      Jade Jaffar

       

      SIG AWARDS

      Supported by TSANZ

      Cell, Immunology and Molecular Biology: Dhammika Leshan

      Evidence-based Medicine and Practice: Yet Hong Khor

      Peter van Asperen Paediatric: Kiara Sclip

      Physiotherapy: Jamie Wood

      Respiratory Infectious Disease: Benjamin Diggins

      Tobacco: Henry Gomez

      Supported by Asthma Australia

      Asthma & Allergy: Teresa Williams

      Supported by National Asthma Council

      Asthma & Allergy : Cherry Thompson

      Supported by Lung Foundation Australia

      Pulmonary Physiology and Sleep, John Reid Prize: Graeme Zosky

      David Serisier Memorial Award for Translational Research in Bronchiectasis: Su Wei Khung

      Supported by Cystic Fibrosis Australia

      Cystic Fibrosis: Elena Schneider-Futschik

      Supported by Maurice Blackburn

      Lung Cancer: Lara Edbrooke

      Occ Env Lung Disease / Population Health: Edward Harris

      Palliative Care and Symptom Support: Thomas Moran

      Supported by Carroll & O’Dea

      Interventional Pulmonology and Bronchoscopy: Deirdre Fitzgerald

      Supported by Boehringer Ingelheim

      Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease: Jemma Seyfang

      Primary Care: Mary Roberts

      Chronic Obstructive Pulmonary Disease: Sonia Cheng

      Respiratory Nurses: Jane Neil

      TSANZ Best Poster: Kris Nilsen: A new tool to monitor disease in IPF

      CONGRATULATIONS TO…

      TSANZ would also like to take this opportunity to congratulate the following New Fellows for 2019:

      • Prof Anne Holland
      • Dr Denise O’Driscoll
      • Dr Jane Bourke
      • A/Prof Jeff Garrett
      • Prof Paul Foster
      • Prof Peter Eastwood
      • Prof Sandra Hodge

       

      Open Awards

      Thoracic Society Awards

      AstraZeneca Respiratory Research Fellowships – closes 2nd June 2019

      Vertex Adult Cystic Fibrosis Research Award – closes 2nd June 2019

      Vertex Paediatric Cystic Fibrosis Research Award – closes 2nd June 2019

      Lung Foundation Awards

      Lung Foundation Australia Brian Eaton Memorial PhD Scholarship in IPF – closes 10th June 2019

      Lung Foundation Australia Diana Cox PhD Scholarship in IPF – closes 10th June 2019

      Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

      Travel application deadlines

      ATS: 22nd March 2019 (5pm AEST)

      ERS: 31st July 2019 (5pm AEST)

      APSR: 13th September 2019 (5pm AEST)

       

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

      Respirology – Editor’s Choice

      Respirology Issue 24.4 2019

      Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

      Helen E. Jo, Ian Glaspole, Nicole Goh, Peter M.A. Hopkins, Yuben Moodley, Paul N. Reynolds, Sally Chapman, Eugene Haydn Walters, Christopher Zappala, Heather Allan, Sacha Macansh, Christopher Grainge, Gregory J. Keir, Andrew Hayen, Douglas Henderson, Sonja Klebe, Stefan B. Heinze, Anne Miller, Hannah C. Rouse, Edwina Duhig, Wendy A. Cooper, Annabelle M. Mahar, Samantha Ellis, Samuel R. McCormack, Bernard Ng, David B. Godbolt, Tamera J. Corte

      DOI: 10.1111/resp.13427 

      Distribution of participants in the Australian IPF Registry

       

      A consensus opinion amongst stakeholders as to benefits of obstructive sleep apnoea treatment for cardiovascular health

      Shane A. Landry, Siobhan Banks, Peter A. Cistulli, Garun S. Hamilton, Laure Héraud, Kristina Kairaitis, Steven Lubke, Sutapa Mukherjee, Teanau Roebuck, Joesph Soda, Darren Umbers, Shantha M. W. Rajaratnam, Darren Mansfield.

      DOI: 10.1111/resp.13413

       

      From left to right: Prof Shantha Rajaratnam, Dr Shane Landry, A/Prof Darren Mansfield from Monash University and the Monash Medical Centre in Melbourne, Australia

      Research Project and Survey Requests

      Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

      If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

      We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach consensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

      A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

      For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

      If you agree to participate, please follow the link to complete the survey

      http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

      *for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

      Thank you,

      Peter Wark
      Jodie Simpson
      J. Michael Ramsahai
       JamesMichael.Ramsahai@uon.edu.au

       

      Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

      To Members of the Thoracic Society of Australia and New Zealand,

      Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

      The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

      Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

      Thank you for your kind support.

      Yours truly

      Rachel McLellan, Advanced RACP Trainee
      Kwun Fong
      Henry Marshall
      Rayleen Bowman
      Ian Yang

      University of Queensland Thoracic Research Centre at The Prince Charles Hospital
      Metro North Hospital and Health Service | Queensland Government
      Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
      t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

       

       

      New survey about Victorian doctors’ end-of-life decision-making

      Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

      At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

      A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

      If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

       

      Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

      Dear TSANZ Member,

      You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

      The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD

      If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

      We thank you in advance for your participation.

      Sincerely,

      Van Holden, MD
      Mihir Parikh, MD
      Alex Chee, MD
      Adnan Majid, MD

      Division of Thoracic Surgery & Interventional Pulmonology
      Beth Israel Deaconess Medical Center
      Harvard Medical School

      The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

       
       

      .

      VOLUME 7.05 – JUNE 2022

      VOLUME 3.04 JULY 2018

      Research Roundup:

      July 2018

      .
       

      Welcome Message

       

      We want to share with you some good news for Respirology – the 2017 impact factors have been announced and Respirology’s impact factor has increased to 4.4 (from 3.25 in 2016). The journal’s ranking among the Respiratory System journals has also increased to 10/59(from 18/59 in 2016). The Research Roundup has been featuring the Respirology Editors Choice for one year now. We would like to Congratulate the team and thank past editor Peter Eastwood and current editors Phil Bardin and Paul Reynolds on this impressive growth in citations. We look forward to your future publications!

      Now to awards – a number of grants-in-aid and travel awards are closing soon. The Lung Foundation Australia have also just opened up two new memorial awards for Interstitial Lung Disease. Please look to the open awards below so that you do not miss out.

      We would like to highlight the next endeavour from Bill van Nierop who is launching his second Lung campaign – Long Kayak for Lungs. This campaign aims to raise awareness and understanding of lung diseases within the community, remove the stigma often linked to those with a lung disease, help change community attitudes to this insidious disease group and raise some much needed funds on route. Bill attended our TSANZSRS18 to present a PhD scholarship which is supported through funds he raised in his last campaign. See the story of Bill’s next adventure below.

      Enjoy the July edition of your research roundup.

      Profs Phil Hansbro & Sandra Hodge

      Co-Chairs, Research Sub-Committee

      Open Awards

      TSANZ NZ Branch ASM Travel Grant – closes 14 Jul 18

      Lung Foundation Australia / Eleanor Greenwood Memorial Interstitial Lung Disease Travel Grant 2018 – closes 3 Aug 18

      Lung Foundation Australia / Eleanor Greenwood Memorial Grant-in-Aid for Interstitial Lung Disease 2018/19 closes 3 Aug 18

      Vertex Cystic Fibrosis Research Awards – NACFC closes 08 Aug 18

      Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards – (APSR) extended to 17th Aug Jul 18

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

       

      Long Kayak for Lungs

      Following on from the successful Long walk for Lungs last year , Bill Van Nierop has raised the bar in his ongoing endeavours  in supporting  Lung Foundation Australia with their  efforts in research and patient support with a remarkable new challenge for 2018, The Long Kayak for Lungs, 42 Days/2,200 Km’s Albury NSW to the Murray Mouth in South Aust.

      This 2,200 km initiative is all about furthering the awareness and understanding of lung diseases within the community, remove the stigma often linked to those with a lung disease, help change community attitudes to this insidious disease group and raise some much needed funds on route.

      Funds raised via the Long Walk for Lungs were used to initiate a PHD Scholarship in Idiopathic Pulmonary Fibrosis Research, support for Lung Foundation Patient Support groups, and contribute to the funding for a future respiratory nurse to support patients across Australia.

      Bill is determined to paddle the distance and raise vital research funding to support Australians living with lung diseases like IPF.

      ​Bill lives in Brisbane, working for AGnVET Services. Bill is married to Lesley with 3 children and 5 grand kids, who Bill would like to be around to see grow up.

      Support Bill’s efforts at www.longkayakforlungs.com.au and follow his journey.

      FLYER

      _____________________________________________________________________________

      Lung Foundation Cycle Challenge 

      The Thoracic Society of Australia and New Zealand (TSANZ) is raising much needed funds for Lung Foundation Australia by participating in The Corporate Cycle Challenge 2018. On Friday 3rd August, TSANZ Staff will participate in this challenge to support the work of the Lung Foundation Australia.

      TSANZ is the only health peak body representing a range of professions (medical specialists, scientists, researchers, academics, nurses, physiotherapists, students and others) across various disciplines within the respiratory/sleep medicine field in Australia and New Zealand.

      TSANZ is committed to serving the professional needs of its members by improving knowledge and understanding of lung disease, with the ultimate goals being to prevent respiratory illness through research and health promotion and to improve health care for people with respiratory illness.

      You can help, too! Please CLICK HERE to donate or if you are interested in joining the challenge.

      Any amount you can give makes a difference. Thank you for your generosity and support!

      Respirology – Editor’s Choice

      Respirology Issue 23.7 (July 2018)

      Segmentectomy versus Lobectomy in Early Non-Small Cell Lung Cancer of 2 cm or less in Size: A Population-Based Study

      MI HYOUNG MOON, YOUNG KYU MOON and SEOK WHAN MOON
      DOI: 10.1111/resp.13277

       

      Research team from the Catholic University of Korea in Seoul. From left to right: Drs Young Kyu Moon, Mi Hyoung Moon and Seok Whan Moon.

       

      Ethnic differences in lung function in China: results from a large community-based epidemiological study

      RUOHUA YAN, LAP AH TSE, ZHIGUANG LIU, JIAN BO, EMILY Y. CHAN, YANG WANG,
      LU YIN,WEI LI on behalf of PURE-China Investigators
      DOI: 10.1111/resp.13258

       

      Research team from the National Center for Cardiovascular Diseases and the Chinese University of Hong Kong, China. Left to right: Jian Bo (inset), Zhiguang Liu, Ruohua Yan, Lu Yin, Wei Li, Lap Ah Tse, Emily Y. Chan and Yang Wang.

       

      Research Project and Survey Requests

      The Global Lung Function Initiative (GLI) Survey

      The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

       As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

      This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

      We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

      Survey sent on behalf of the Global Lung Function Initiative Network: 

      https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

       

      Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

      ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

      Cough in lung cancer – a health professional survey

      The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

      Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

      We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

      Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

      This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

      For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

       
       
       
       
       
       
       

      .

      VOLUME 7.05 – JUNE 2022

      VOLUME 3.01 FEBRUARY 2018

      Research Roundup:

      February 2018

      .
       

      Welcome Message

      Welcome to the first Research Roundup of 2018. The Research Subcommittee are currently working their way through reviewing the many award applications received in the last couple of months. This year, for the first time and together with Lung Foundation Australia and Cystic Fibrosis Australia, we will be awarding $1 million worth of research funding at the TSANZSRS in Adelaide. We thank our generous sponsors and organisational partners for enabling our world-class researchers to continue to create respiratory knowledge with the goal to prevent, cure and relieve disability from lung disease.

      The ASM is the flagship event of the year where our Society comes together, and this is also a good time for us to share our research stories. We would like to invite all members who have a research story; from an idea to an outcome, to share with this us. This story will be developed further at the ASM with our media partners and help to showcase our research talent and leverage our research profile. Please see the Tell Your Story article within this newsletter for more information.

      We are proud to advise that the TSANZ Board has endorsed our first ever Research Strategy. This strategy outlines what we support: research projects, career development, advocacy driven research, and indigenous health, and how we do this: through direct-to-researcher funding, partnerships, and providing infrastructure. This strategy is underpinned by good governance and upholding equity and diversity across our robust and independent research administration.

      We wish you all the best in your work and in preparation of your grants.

      Enjoy the February edition of your research roundup.

      Prof Phil Hansbro

      Prof Sandra Hodge

      Co-Chairs, Research Sub-Committee

      Open Awards

      Maurice Blackburn ASM Travel Award 2018

      These travel awards are made available to encourage eligible TSANZ members to attend and enrich the TSANZ Annual Scientific Meeting (ASM) through presentation of their work and active participation in the meeting. There will be one award of AUD 1500 to support the career development of TSANZ nurses, physiotherapists and other allied health professionals who do not already receive travel support from their institution.

      How to participate

      Follow the links above to access each award application form and download the information sheet.

      Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

      Watch this space for more award announcements…

      Tell Your Story

      During 2017, the Research Subcommittee drafted the TSANZ Research Strategy and this was endorsed at the last TSANZ Board meeting of 2017.

      This strategy outlines what we support:

      • Research projects
      • Career development
      • Advocacy driven research, and
      • Indigenous health

      We do this through direct-to-researcher funding, partnerships, and providing infrastructure. This strategy is underpinned by good governance and upholding equity and diversity across our robust and independent research administration. 

      Whilst things are improving, and now we even have the Cardiorespiratory Field of Research, there is still a way to go in promoting Respiratory Research.

      We would like to showcase our member’s research stories. If you have a story about an idea or an observation which you have followed through and been able to deliver outcomes on, we would like to know about it.

      Telling these stories to the general public, government, and industry, will help to raise the profile of respiratory research and peoples desire to support it.

      Respirology Issue 23.2 – Editor’s Choice

      Non-invasive ventilation during cycle exercise training in patients with chronic respiratory failure on long-term ventilatory support: A randomized controlled trial

      MICHELE VITACCA, DICLE KAYMAZ, BARBARA LANINI, GUIDO VAGHEGGINI, PINAR ERGÜN, FRANCESCO GIGLIOTTI, NICOLINO AMBROSINO AND MARA PANERONI

      DOI: 10.1111/resp.13181

       

      The respiratory division team at the main centre of the international collaborative research project in Lumezzane, Italia, including authors Michele Vitacca and Mara Paneroni (first and second person from the right side).

       

      Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure

      DONGXING ZHAO, YUMIN ZHOU, CHANGBIN JIANG, ZHUXIANG ZHAO, FANG HE AND PIXIN RAN

      DOI: 10.1111/resp.13176

       

      The First Affiliated Hospital of the Guangzhou Medical University on the river bank of the Pearl river in Guangzhou, China, where the research study was performed. 

      Research Project and Survey Requests

      Explaining chronic breathlessness

      Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

      We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

      This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

      Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

      For further information or to participate, please click here: 

      Explain chronic breathlessness’   or copy and paste the following into your browser:

      https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

      For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

       

      ‘Usual’ antenatal asthma management

      Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma managementconsists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

      If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

      Ethics approval has been granted for this study (NSW HREC Reference No: HREC/16/HNE/394).  All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

      Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:

      https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

      Thank you,

      Dr Vanessa Murphy, Vanessa.Murphy@newcastle.edu.au
      Ms Karen McLaughlin, Karen.McLaughlin@hnehealth.nsw.gov.au 

      .

      WHY JOIN US?

      Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

      By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

      X